Annual SG&A
$8.10B$411.00M-4.83%
Summary
- Current Value
- As of today, MCK annual SG&A is $8.10B, down -4.83% on
- Historical Performance
- MCK annual SG&A is up +4.12% over the past 3 years, down -8.51% over the past 5 years
- All-Time High Comparison
- MCK annual SG&A is currently -23.17% below its historical high of $10.54B set on
- 3-Year Low Comparison
- MCK annual SG&A is +4.12% above its 3-year low of $7.78B reached on an earlier date
- Sector Comparison
- MCK annual SG&A is higher than 99.91% of companies in Healthcare sector
SG&A Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $8.10B | -4.8% | +4.1% | -8.5% | +129.4% | |
| Quarterly SG&A | $2.27B | +9.4% | +8.5% | -15.0% | +115.9% | |
| TTM SG&A | $89.73B | +984.5% | +1046.1% | +852.9% | +2046.0% | |
| Price | $1,062.51 | +24.6% | +136.0% | +381.0% | +1228.0% | |
| Annual Operating Expenses | $8.10B | -0.1% | +9.3% | +0.4% | +108.1% | |
| Annual Operating Profit | $5.95B | +36.1% | +33.6% | +69.5% | +183.7% | |
| Annual D&A | $729.00M | +14.6% | -14.9% | -40.3% | +47.0% | |
| Annual Revenue | $403.43B | +12.4% | +45.8% | +69.3% | +259.9% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $8.66B | -6.5% | |
| 5Y | $10.54B | -23.2% | |
| All | $10.54B | -23.2% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $7.78B | N/A | +4.1% |
| 5Y | $7.78B | +4.1% | |
| All | $0.00 | N/A |
SG&A History
FAQ
- What is the current annual SG&A of MCK?
- As of today, MCK annual SG&A is $8.10B
- What is 1-year change in MCK annual SG&A?
- MCK annual SG&A is down -4.83% year-over-year
- What is 3-year change in MCK annual SG&A?
- MCK annual SG&A is up +4.12% over the past 3 years
- How far is MCK annual SG&A from its all-time high?
- MCK annual SG&A is currently -23.17% below its historical high of $10.54B set on March 31, 2022
- How does MCK annual SG&A rank versus sector peers?
- MCK annual SG&A is higher than 99.91% of companies in Healthcare sector
- When is MCK next annual earnings release?
- As of today, the next annual earnings release for MCK has not been scheduled
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Quarterly SG&A
$2.27B$5.00M+0.22%
Summary
- Current Value
- As of today, MCK quarterly SG&A is $2.27B, up +0.22% on
- Historical Performance
- MCK quarterly SG&A is up +9.40% year-over-year, up +8.46% over the past 3 years
- All-Time High Comparison
- MCK quarterly SG&A is currently -26.92% below its historical high of $3.11B set on
- 3-Year Low Comparison
- MCK quarterly SG&A is +26.34% above its 3-year low of $1.80B reached on
- Sector Comparison
- MCK quarterly SG&A is higher than 98.59% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $2.27B | +0.2% | +9.4% | +8.5% | -15.0% | |
| Annual SG&A | $8.10B | – | -4.8% | +4.1% | -8.5% | |
| TTM SG&A | $89.73B | +999.0% | +984.5% | +1046.1% | +852.9% | |
| Price | $1,062.51 | +24.5% | +24.6% | +136.0% | +381.0% | |
| Quarterly Operating Expenses | $2.02B | -2.3% | +7.2% | +1.1% | -20.5% | |
| Quarterly Operating Profit | $1.79B | +25.8% | +27.3% | +99.1% | +161.8% | |
| Quarterly D&A | $197.00M | +1.0% | +4.8% | -10.9% | -23.4% | |
| Quarterly Revenue | $110.96B | +5.3% | +7.6% | +43.7% | +66.7% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.27B | at high | |
| 3Y | $2.51B | -9.5% | |
| 5Y | $3.11B | -26.9% | |
| All | $3.11B | -26.9% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.80B | +26.3% | |
| 3Y | $1.80B | +26.3% | |
| 5Y | $1.80B | +26.3% | |
| All | -$79.90M | +2939.8% |
Quarterly SG&A History
FAQ
- What is the current quarterly SG&A of MCK?
- As of today, MCK quarterly SG&A is $2.27B
- What is MCK quarterly SG&A most recent change?
- MCK quarterly SG&A was up +0.22% on September 30, 2026
- What is 1-year change in MCK quarterly SG&A?
- MCK quarterly SG&A is up +9.40% year-over-year
- How far is MCK quarterly SG&A from its all-time high?
- MCK quarterly SG&A is currently -26.92% below its historical high of $3.11B set on December 31, 2021
- How does MCK quarterly SG&A rank versus sector peers?
- MCK quarterly SG&A is higher than 98.59% of companies in Healthcare sector
- When is MCK next earnings release?
- The next earnings release for MCK is on
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
TTM SG&A
$89.73B$4.29B+5.03%
Summary
- Current Value
- As of today, MCK TTM SG&A is $89.73B, up +5.03% on
- Historical Performance
- MCK TTM SG&A is up +984.55% year-over-year, up +1046.06% over the past 3 years
- All-Time High Comparison
- MCK TTM SG&A is currently at its all-time high
- 3-Year Low Comparison
- MCK TTM SG&A is +76.55% above its 3-year low of $50.82B reached on an earlier date
- Sector Comparison
- MCK TTM SG&A is higher than 98.56% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $89.73B | +999.0% | +984.5% | +1046.1% | +852.9% | |
| Annual SG&A | $8.10B | – | -4.8% | +4.1% | -8.5% | |
| Quarterly SG&A | $2.27B | +0.2% | +9.4% | +8.5% | -15.0% | |
| Price | $1,062.51 | +24.5% | +24.6% | +136.0% | +381.0% | |
| TTM Operating Profit | $7.10B | +5.7% | +47.8% | +70.0% | +103.6% | |
| TTM D&A | $776.00M | +1.2% | +19.6% | -10.8% | -34.0% | |
| TTM Revenue | $418.79B | +1.9% | +8.2% | +43.9% | +66.8% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $89.73B | N/A | at high |
| 3Y | $89.73B | N/A | at high |
| 5Y | $89.73B | N/A | at high |
| All | $89.73B | N/A | at high |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $72.91B | N/A | +23.1% |
| 3Y | $50.82B | N/A | +76.5% |
| 5Y | $33.23B | N/A | +170.0% |
| All | $862.10M | N/A | >+9999.0% |
TTM SG&A History
FAQ
- What is the current TTM SG&A of MCK?
- As of today, MCK TTM SG&A is $89.73B
- What is MCK TTM SG&A most recent change?
- MCK TTM SG&A was up +5.03% on September 30, 2026
- What is 1-year change in MCK TTM SG&A?
- MCK TTM SG&A is up +984.55% year-over-year
- How far is MCK TTM SG&A from its all-time high?
- MCK TTM SG&A is currently at its all-time high
- How does MCK TTM SG&A rank versus sector peers?
- MCK TTM SG&A is higher than 98.56% of companies in Healthcare sector
- When is MCK next earnings release?
- The next earnings release for MCK is on
SG&A Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Data Sources & References
- MCK Official Website www.mckesson.com
- MCK Profile on Yahoo Finance finance.yahoo.com/quote/MCK
- MCK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mck
